Articoli

I batteri Gram negativi multiresistenti: un problema emergente e di attualita’. Indicazioni gestionali.

Documento approvato dal Consiglio Direttivo Simpios il 27 settembre 2010

Leggi

 

Recommendations for the management of Carbapenem-resistant Enterobacteriaceae (CRE) in acute and long-term acute care hospitals.

Minnesota Department of Health. Aprile 2011

Leggi

Guidelines for the prevention and control of multi-drug resistant organisms (MDRO) excluding MRSA in the healthcare setting. 2012

Dublin: Royal College of Physicians (RCPI) Healthcare Associated Infections of Ireland in association with HSE Quality and Patient Safety

Leggi

Acute trust toolkit for the early detection, management and control of Carbapenemase-producing Enterobacteriaceae.

Public Health England, 2013

Leggi

Circolare ministeriale “Sorveglianza, e controllo delle infezioni da batteri produttori di Carbapenemasi (CPE)”

Circolare Ministeriale. Febbraio 2013

Leggi

Acute trust toolkit for the early detection, management and control of Carbapenemase-producing Enterobacteriaceae. Relevant literature and resources.

Public Health England, 2014.

Leggi

Systematic review of the effectiveness of infection control measures to prevent the transmission of Carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients.

ECDC Technical Report, 2014

Leggi

AHRQ. Carbapenem-Resistant Enterobacteriaceae (CRE) control and prevention toolkit.

Agency for Healthcare Research and Quality U.S. Department of Health and Human Services, 2014

Leggi

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients.

ESCMID Linee guida. 2014

Leggi

Guidelines prevention and control of multi-drug-resistant gram-negative bacteria: recommendations from a joint working party

HIS Working Party Report, 2015

Leggi